Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...

GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support ...

These new supplemental products are offering similar benefits to drugs like Ozempic - but experts say it may be a placebo ...

At first, Nour Mansour was thrilled by the effects of weight-loss jab Mounjaro - dropping from a size 18 to a size 8 in less ...

Ali Eastburn was looking forward to her son's wedding when her side-effects from weight loss drugs went from bad to worse ...

Embecta Corp (EMBC) reports strong third-quarter growth and strategic advancements, while navigating geopolitical and market challenges.

One in five older Indian adults had diabetes in 2019, says a Lancet study. What are the key highlights of the study? What is ...

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a ...

Now, Eli Lilly says its experimental GLP-1 pill is a success after the first phase-three trial. The company said more than 3,000 adults on the experimental oral medication lowered their weight by an ...

Significant regulatory advances for lead candidate EB613 streamline Phase 3 clinical development and reduce regulatory hurdles. These 10 stocks could mint the next wave of millionaires › Entera Bio ...

Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...

Scientists have found new evidence that Ozempic can help reverse aging — yet another health benefit added to the laundry list ...